Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.

CONCLUSION: Leveraging pharmacists to extend access to MOUD, particularly buprenorphine, remains an underutilized strategy that should be implemented, particularly during the concurrent COVID-19 global pandemic. PMID: 33411894 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33411894?dopt=Abstract

Source: American Journal of Health-System Pharmacy : AJHP - January 7, 2021 Category: Drugs & Pharmacology Authors: Peckham AM, Ball J, Colvard MD, Dadiomov D, Hill LG, Nichols SD, Tallian K, Ventricelli DJ, Tran TH Tags: Am J Health Syst Pharm Source Type: research

More News: Academia | Coronavirus | COVID-19 | Drugs & Pharmacology | Pandemics